📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Lipopeptidomimetics derived from teixobactin have potent antibacterial activity against Staphylococcus aureus. (2018)

First Author: Girt GC

Attributed to: Substrate Peptidomimetic Inhibitors (SPIs) of the COP9 signalosome funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1039/c7cc06093a

PubMed Identifier: 29484340

Publication URI: http://europepmc.org/abstract/MED/29484340

Type: Journal Article/Review

Volume: 54

Parent Publication: Chemical communications (Cambridge, England)

Issue: 22

ISSN: 1359-7345